| The predictive approaches to treatment effect heterogeneity (PATH) statement DM Kent, JK Paulus, D Van Klaveren, R D'Agostino, S Goodman, ... Annals of internal medicine 172 (1), 35-45, 2020 | 276 | 2020 |
| Assessing the financial value of patient engagement: a quantitative approach from CTTI’s patient groups and clinical trials project B Levitan, K Getz, EL Eisenstein, M Goldberg, M Harker, S Hesterlee, ... Therapeutic innovation & regulatory science 52 (2), 220-229, 2018 | 139 | 2018 |
| The predictive approaches to treatment effect heterogeneity (PATH) statement: explanation and elaboration DM Kent, D Van Klaveren, JK Paulus, R D'Agostino, S Goodman, ... Annals of internal medicine 172 (1), W1-W25, 2020 | 120 | 2020 |
| Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline T Kuijpers, FA Spencer, RAC Siemieniuk, PO Vandvik, CM Otto, L Lytvyn, ... Bmj 362, 2018 | 110 | 2018 |
| Use of altered informed consent in pragmatic clinical research RE McKinney Jr, LM Beskow, DE Ford, JD Lantos, J McCall, ... Clinical Trials 12 (5), 494-502, 2015 | 104 | 2015 |
| Digital measures that matter to patients: a framework to guide the selection and development of digital measures of health C Manta, B Patrick-Lake, JC Goldsack Digital Biomarkers 4 (3), 69-77, 2020 | 96 | 2020 |
| Technology-enabled clinical trials: transforming medical evidence generation G Marquis-Gravel, MT Roe, MP Turakhia, W Boden, R Temple, A Sharma, ... Circulation 140 (17), 1426-1436, 2019 | 76 | 2019 |
| Patient engagement practices in clinical research among patient groups, industry, and academia in the United States: a survey SK Smith, W Selig, M Harker, JN Roberts, S Hesterlee, D Leventhal, ... PloS one 10 (10), e0140232, 2015 | 75 | 2015 |
| Inclusion and diversity in clinical trials: actionable steps to drive lasting change MD Kelsey, B Patrick-Lake, R Abdulai, UC Broedl, A Brown, E Cohn, ... Contemporary clinical trials 116, 106740, 2022 | 58 | 2022 |
| The Project Baseline Health Study: a step towards a broader mission to map human health K Arges, T Assimes, V Bajaj, S Balu, MR Bashir, L Beskow, R Blanco, ... NPJ digital medicine 3 (1), 84, 2020 | 47 | 2020 |
| The rules of engagement: CTTI recommendations for successful collaborations between sponsors and patient groups around clinical trials D Bloom, J Beetsch, M Harker, S Hesterlee, P Moreira, B Patrick-Lake, ... Therapeutic Innovation & Regulatory Science 52 (2), 206-213, 2018 | 42 | 2018 |
| Evaluation, acceptance, and qualification of digital measures: from proof of concept to endpoint JC Goldsack, AV Dowling, D Samuelson, B Patrick-Lake, I Clay Digital biomarkers 5 (1), 53-64, 2021 | 37 | 2021 |
| Patient engagement in clinical trials: The Clinical Trials Transformation Initiative’s leadership from theory to practical implementation B Patrick-Lake Clinical Trials 15 (1_suppl), 19-22, 2018 | 37 | 2018 |
| Harmonization and streamlining of research oversight for pragmatic clinical trials PP O’Rourke, J Carrithers, B Patrick-Lake, TW Rice, J Corsmo, R Hart, ... Clinical Trials 12 (5), 449-456, 2015 | 29 | 2015 |
| Remote digital monitoring for medical product development ES Izmailova, JA Wagner, N Ammour, N Amondikar, A Bell‐Vlasov, ... Clinical and translational science 14 (1), 94-101, 2021 | 18 | 2021 |
| The path forward for digital measures: suppressing the desire to compare apples and pineapples CR Houts, B Patrick-Lake, I Clay, RJ Wirth Digital Biomarkers 4 (Suppl. 1), 3-12, 2020 | 17 | 2020 |
| Return of individual research results: What do participants prefer and expect? S Sayeed, R Califf, R Green, C Wong, K Mahaffey, SS Gambhir, J Mega, ... PloS one 16 (7), e0254153, 2021 | 12 | 2021 |
| Mind the gap: the ethics void created by the rise of citizen science in health and biomedical research B Patrick-Lake, JC Goldsack The American Journal of Bioethics 19 (8), 1-2, 2019 | 10 | 2019 |
| Hearing voices: FDA seeks advice from patients SF Terry, B Patrick-Lake Science Translational Medicine 7 (313), 313ed12-313ed12, 2015 | 8 | 2015 |
| Development and application of a patient group engagement prioritization tool for use in medical product development B Perry, C Dombeck, JB Smalley, B Levitan, D Leventhal, B Patrick-Lake, ... Therapeutic Innovation & Regulatory Science 55 (2), 324-335, 2021 | 4 | 2021 |
